Guardant Health
GH
#3559
Rank
A$4.62 B
Marketcap
$37.63
Share price
-1.18%
Change (1 day)
-11.90%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: A$4.62 Billion

As of September 2024 Guardant Health has a market cap of A$4.62 Billion. This makes Guardant Health the world's 3559th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024A$4.62 B-3.94%
2023A$4.81 B17.7%
2022A$4.09 B-70.72%
2021A$13.98 B-16.37%
2020A$16.72 B60.18%
2019A$10.43 B128.21%
2018A$4.57 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Guardant Health was reported to be:

A$4.62 Billion
by Yahoo Finance info icon info icon
A$4.62 Billion
by CompaniesMarketCap info icon info icon
A$4.62 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
A$23.70 B 412.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.67 B 22.58%๐Ÿ‡บ๐Ÿ‡ธ USA